Viromed Medical (VMED.DE) stock: key figures, P/E, revenue and dividend
Health Care · Germany · ISIN DE000A40ZVN7
Price
5.35 EUR
Market cap
113.69 m EUR
P/E (2025)
188.06
P/S (2025)
22.35
Dividend yield
0.00 %
Net margin
11.88 %
Return on equity (ROE)
5.77 %
Return on assets (ROA)
4.34 %
Viromed Medical financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 0.00 EUR | 5.09 m EUR |
| Gross profit | 0.00 EUR | 2.29 m EUR |
| Operating income | – | -862,273.32 EUR |
| EBIT | 0.00 EUR | – |
| Net income | 0.00 EUR | 604,514.36 EUR |
| Diluted EPS – continuing operations | -0.01 EUR | 0.03 EUR |
Full history since 2021, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Viromed Medical
Viromed Medical AG engages in the development and distribution of products in diagnostics, therapeutics, and cold plasma technology. The company was formerly known as Fonterelli SPAC2 AG. Viromed Medical AG was incorporated in 2021 and is based in Pinneberg, Germany.
More stocks
- Silver X Mining Corp (AGX.V)
- Gorilla Gold Mines Ltd (GG8.AX)
- Diamond Building Products Public Company Limited (DRT.BK)
- Chialin Precision Industrial Co Ltd (3310.TWO)
- TILLY'S, INC. (TLYS)
- RIVERVIEW BANCORP INC (RVSB)
- Sable Offshore Corp. (SOC)
- Wendell Industrial Co. Ltd (6761.TWO)
- Securitag Assembly Group Co Ltd (6417.TWO)
- Kangnam Jevisco Co Ltd (000860.KS)
- Prime Office A/S (PRIMOF.CO)
- Global Cord Blood Corporation (CORBF)
Not investment advice. All data without warranty, price as of 10.09.2026. Details in the risk notice.